Ulinastatin attenuates isoflurane-induced cognitive dysfunction in aged rats by inhibiting neuroinflammation and β-amyloid peptide expression in the brain. (3rd October 2019)
- Record Type:
- Journal Article
- Title:
- Ulinastatin attenuates isoflurane-induced cognitive dysfunction in aged rats by inhibiting neuroinflammation and β-amyloid peptide expression in the brain. (3rd October 2019)
- Main Title:
- Ulinastatin attenuates isoflurane-induced cognitive dysfunction in aged rats by inhibiting neuroinflammation and β-amyloid peptide expression in the brain
- Authors:
- Guo, Mingyan
Zhu, Xiaoqiu
Xu, Hui
Li, Jin
Yang, Shangze
Zuo, Zhiyi
Lin, Daowei - Abstract:
- ABSTRACT: Objective : Postoperative neurocognitive disease (PNCD) in the aged is a major clinical problem with unclear mechanisms. This study was designed to explore the mechanisms for ulinastatin (UTI) to attenuate isoflurane-induced cognitive decline in Fischer-344 rats. Methods : The rats were divided into four groups: Control (0.9% saline only), Isoflurane (exposure to 1.2% isoflurane), Isoflurane-plus-UTI (exposure to 1.2% isoflurane followed by 100, 000 U/kg UTI injection i.v .) and UTI-plus-isoflurane (i.v. of 100, 000 U/kg UTI followed by 1.2% isoflurane exposure). After respective tests, the concentrations of tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the brain were determined by ELISA the expression of β-amyloid peptide (Aβ) and cleaved caspase-3 were measured by Western blot. Ratio of apoptotic cells after Barnes maze challenge was assessed by TUNEL assay. Results : In both Barnes Maze training and challenge, results indicated isoflurane-impaired learning capacity, while pre-and post-treatment with UTI could attenuate this phenomenon. The ratio of apoptotic cells and the expression of cleaved caspase-3 were increased after isoflurane exposure, indicating that isoflurane could induce neuronal apoptosis, while both pre- and post-treatment with UTI could diminish these effects. Moreover, UTI inhibited the expression of TNF-α, IL-1β and Aβ induced by isoflurane in rat brain harvested at 16 h after isoflurane exposure. Conclusion : These resultsABSTRACT: Objective : Postoperative neurocognitive disease (PNCD) in the aged is a major clinical problem with unclear mechanisms. This study was designed to explore the mechanisms for ulinastatin (UTI) to attenuate isoflurane-induced cognitive decline in Fischer-344 rats. Methods : The rats were divided into four groups: Control (0.9% saline only), Isoflurane (exposure to 1.2% isoflurane), Isoflurane-plus-UTI (exposure to 1.2% isoflurane followed by 100, 000 U/kg UTI injection i.v .) and UTI-plus-isoflurane (i.v. of 100, 000 U/kg UTI followed by 1.2% isoflurane exposure). After respective tests, the concentrations of tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the brain were determined by ELISA the expression of β-amyloid peptide (Aβ) and cleaved caspase-3 were measured by Western blot. Ratio of apoptotic cells after Barnes maze challenge was assessed by TUNEL assay. Results : In both Barnes Maze training and challenge, results indicated isoflurane-impaired learning capacity, while pre-and post-treatment with UTI could attenuate this phenomenon. The ratio of apoptotic cells and the expression of cleaved caspase-3 were increased after isoflurane exposure, indicating that isoflurane could induce neuronal apoptosis, while both pre- and post-treatment with UTI could diminish these effects. Moreover, UTI inhibited the expression of TNF-α, IL-1β and Aβ induced by isoflurane in rat brain harvested at 16 h after isoflurane exposure. Conclusion : These results suggest that UTI inhibits neuronal apoptosis in rat brain by attenuating increased expression of Aβ42 and inflammatory cytokines, which may contribute to its alleviation of isoflurane-induced cognitive dysfunction in rats. Moreover, UTI pre-treatment before isoflurane exposure showed more effective than post-treatment. … (more)
- Is Part Of:
- Neurological research. Volume 41:Number 10(2019)
- Journal:
- Neurological research
- Issue:
- Volume 41:Number 10(2019)
- Issue Display:
- Volume 41, Issue 10 (2019)
- Year:
- 2019
- Volume:
- 41
- Issue:
- 10
- Issue Sort Value:
- 2019-0041-0010-0000
- Page Start:
- 923
- Page End:
- 929
- Publication Date:
- 2019-10-03
- Subjects:
- Ulinastatin -- postoperative neurocognitive disease -- isoflurane -- β-amyloid peptide -- inflammatory cytokine
Neurology -- Periodicals
Neurosciences -- Periodicals
616.8005 - Journal URLs:
- http://catalog.hathitrust.org/api/volumes/oclc/3983345.html ↗
http://www.ingentaconnect.com/content/maney/nres ↗
http://www.maney.co.uk/search?fwaction=show&fwid=503 ↗
http://www.tandfonline.com/toc/yner20/current ↗
http://maneypublishing.com/ ↗ - DOI:
- 10.1080/01616412.2019.1642564 ↗
- Languages:
- English
- ISSNs:
- 0161-6412
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18544.xml